Actively Recruiting

Age: 18Years +
All Genders
NCT03265379

Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall Resection

Led by University Health Network, Toronto · Updated on 2025-12-03

104

Participants Needed

1

Research Sites

678 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Although chest wall recurrence of breast cancer is uncommon, it represents a difficult clinical scenario. The role of full thickness chest wall resection (FTCWR) for breast cancer recurrence in the chest wall is controversial and is complicated by the fact that no prospective evidence exists evaluating the utility of FTCWR in prolonging survival or improving health related quality of life (HRQOL) and thus, there is a lack of evidence to guide treatment decisions. Gathering HRQOL, local-regional recurrence (LRR) and survival data in a prospective fashion is thus critical in this population. Therefore, we designed a prospective trial to evaluate the outcomes for FTCWR in terms of LRC and HRQOL, and short-term morbidity and mortality, with secondary focus on potential long-term overall survival benefit.

CONDITIONS

Official Title

Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall Resection

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Over 18 years of age
  • Breast cancer invading the chest wall confirmed by imaging
  • Breast cancer invasion confirmed by tissue biopsy
  • Medically fit for surgery
  • More than 1 year disease-free interval since initial treatment for local recurrence
Not Eligible

You will not qualify if you...

  • Medically inoperable due to other health problems or contraindications
  • Disease that cannot be surgically removed
  • Not eligible for chemotherapy
  • Eastern Cooperative Oncology Group (ECOG) performance status greater than 2
  • Patient refusal to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Health Network (Toronto General Hospital and Princess Margaret Cancer Centre)

Toronto, Ontario, Canada, M5G 2C4

Actively Recruiting

Loading map...

Research Team

J

Jennifer Lister, BSc CCRP

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here